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Human Disease Consequences of Fiber
Exposures: A Review of Human Lung
Pathology and Fiber Burden Data
by Victor L. Roggli*
Inhalation of asbestos fibers results in a variety of neoplastic and nonneoplastic diseases of the respi-
ratory tract. Some of these diseases, such as asbestosis, generally occur after prolonged and intensive
exposure to asbestos, whereas others, such as pleural mesothelioma, may occurfollowing briefexposures.
Inhalation of nonasbestiform mineral fibers can occur as well, and these fibers can be recovered from
human lung tissue. Thus, there has been considerable interest in the relationship between mineral fiber
content ofthe lung and various pathologic changes. Techniques for fiber analysis ofhuman tissues have
not been standardized, and consequently results may differ appreciably from one laboratory to another.
In all reported series, extremely high fiber burdens are found in the lungs of individuals with asbestosis.
Although there is a correlation between the tissue concentration of asbestos fibers and the severity of
pulmonary fibrosis, further studies of the mineralogic correlates of fiber-induced pulmonary fibrosis are
needed. Mesothelioma may occur with fiber burdens considerably less than those necessary to produce
asbestosis. More information is needed regarding the migration offibers to the pleura and the numbers,
types, and dimensions of fibers that accumulate at that site. Patients with asbestosis have a markedly
increased risk for lung cancer, but the risk of lung cancer attributable to asbestos in exposed workers
without asbestosis who also smoke is controversial. Combinedepidemiologic-mineralogic studiesofawell-
defined cohort are needed to resolve this issue. In addition, more information is needed regarding the
potential role of nonasbestos mineral fibers in the pathogenesis of lung cancer.
Introduction
The development oftechniques for assaying the min-
eral fiber content of tissues has provided researchers
with the opportunity to correlate the occurrence of var-
iousfiber-related diseaseswiththecumulativefiberbur-
dens in the target organ. Exposure to asbestos gener-
ally occursthrough the inhalation ofairbornefibers, and
thus the respiratory tract is the site of most asbestos-
related diseases. Consequently, most studies of tissue
fiber burdens have concentrated on the analysis oflung
parenchyma. Asbestos is both fibrogenic and carcino-
genic with respect to the respiratory system, with dis-
eases occurring in the pleura (pleural plaques, diffuse
pleural fibrosis, malignant mesothelioma) and in the
lung (asbestosis, bronchogenic carcinoma). The patho-
logic features of these diseases have been reviewed in
detail elsewhere (1-4) and willbe discussed only insofar
as they relate to lung fiber burdens.
Asbestos is not asinglemineralogic entity, butrather
a group ofmineralogic species that share the properties
ofhigh tensile strength, flexibility, and relative thermal
and chemical resistance. Two major groups of asbesti-
form minerals include serpentines and amphiboles.
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Chrysotile asbestos is the sole representative of the
serpentine group, and its structure, chemical compo-
sition, and persistence in biological systems differs ap-
preciably from those of the amphiboles. Commercially
valuable forms of amphibole asbestos include amosite
and crocidolite. Other amphiboles, including actinolite,
anthophyllite, and tremolite, have little or no commer-
cial valuebutmaybe found ascontaminants ofavariety
ofother mineral substances. Details ofthe physical and
chemicalproperties ofthe various asbestiforn minerals
havebeenreviewedelsewhere (5). Inaddition, avariety
ofnonasbestiform fibrous minerals may be identified in
human lung tissue samples, including talc and other
silicates, silica, carbon, metal oxides (such as titanium,
iron, or aluminum), zeolites, and man-made mineral fi-
bers (6-8).
It is the purpose of this review to discuss various
aspects ofhuman lung fiber burden data as they relate
to pulmonary disease. This will include a criticalreview
oftechniques for analyzing lung fiber burdens and the
limitations ofextrapolating results from one laboratory
to another. The results ofmineral fiber analysis in spe-
cific diseases, including asbestosis, mesothelioma, be-
nign pleural diseases, and carcinoma of the lung, will
also be evaluated. Finally, areas where there are gaps
in our knowledge will be specifically identified, with
suggestions for future research directions.V. L. ROGGLI
Techniques for Analysis of
Pulmonary Fiber Burdens
Several techniques have been devised for assaying
mineral fiber content of human lung tissue (7,9-12).
These techniques generally involve three basic steps:
a) dissolution and removal of the organic matrix ma-
terial of the lung in which the fibers are embedded; b)
recovery and concentration ofthe mineral fibers; and c)
analysis of the mineral fiber content by some form of
microscopy. As summarized in Table 1, the actual an-
alytical result obtained on any one sample can be pro-
foundly influenced by the steps in the analytical pro-
cedure employed by the investigator. Indeed, inter-
laboratory comparison trials have shown that striking
differences can occur between laboratories even when
the same sample is analyzed (13). An ongoing interna-
tional interlaboratory comparison study is now drawing
to its close, and should provide information regarding
which steps in the analysis produce the greatest dis-
crepancies. In addition, intralaboratory variation can
occur, which may be either due to changes in a labo-
ratory's procedures overtime (14) ortovariation infiber
content from one site to anotherwithin the lung (15,16).
Such interlaboratory variation makes it difficult to
compare results obtained by different laboratories. This
does not necessarily invalidate the results of human
fiber burden studies, since there is evidence forinternal
consistency within individual laboratories (13). Rather,
one must cautiously compare results between labora-
tories, keeping in mind differences in analytical tech-
niques. Furthermore, when interpreting fiber burden
data, one must realize that the analysis is occurring at
a single point in time, usually when advanced disease
is present. The fiber burden at that point may or may
not relate to the tissue fiber content at the time when
disease was actively evolving-a period ofgreat inter-
Table 1. Factors affecting fiber burden data.
Digestion procedure
Wet chemical digestion (alkali, enzymes)
Low temperature plasma ashing
Number of sites sampled
Recovery procedure
Use of a centrifugation step
Use of a sonication step
Filtration step (type of filter, pore size)
Analytical procedure
Microscopic technique (LM, PCM, TEM, SEM)'
Magnification used
Sizes of fibers counted and other counting rules
Numbers of fibers or fields actually counted
Reporting ofresults
Asbestos bodies or fibers (or both combined)
Sizes of fibers counted
Concentration of fibers (per gram wet or dry lung or per cubic
centimeter)
aLM, light microscopy; PCM, phase contrast microscopy; TEM,
transmission electron microscopy; SEM, scanning electron micros-
copy.
est to investigative biologists. Nonetheless, there is a
growing consensus that the fiber burdens which accu-
mulate in the lung are the primary determinant ofsub-
sequent disease (17).
Asbestosis
Asbestosis is by definition pulmonary interstitial fi-
brosis developing in response to inhalation of asbestos
fibers. The minimal histologic criteria for the diagnosis
ofasbestosis include peribronchiolar fibrosis associated
with accumulations of asbestos bodies (2,18). Some in-
vestigators have challenged the requirement forfinding
asbestos bodies in histologic sections, since some work-
ers are exposed almost exclusively to chrysotile-con-
tainingproducts(19), andchrysotileformsasbestosbod-
ies less readily than amphibole asbestos fibers (20).
However, studies of chrysotile miners and millers (21)
and my own observations oftextile workers exposed to
chrysotile fiber show that asbestos bodies are readily
found in histologic sections of individuals with asbes-
tosis. Furthermore, these asbestos bodies can be shown
by means of energy dispersive spectrometry to have
chrysotile cores (21,22).
Several studies have examined the asbestos content
of lung tissue in series of patients with asbestosis
(18,23-26). These data are summarized in Table 2. The
values obtained are roughly similar amongthe reported
series, with the exception ofthe unusually high median
count for asbestos bodies in the study by Ashcroft and
Heppleston (24) and the high mean count for uncoated
fibers by electron microscopy in the study by Wagner
et al. (26). Most of the discrepancies can be explained
by methodologic differences. For example, Whitwell et
al. (23) used phase contrast light microscopy (PCLM)
and counted all fibers greater than or equal to 6 ,um in
length, counting coated and uncoated fibers together.
Ashcroft and Heppleston (24) used PCLM at a magni-
fication of 400 x and counted all visible fibers, enum-
eratingcoated and uncoated fibers separately. Warnock
et al. (25) usedtransmission electron microscopy (TEM)
and counted allfibersexceeding0.25 ,uminlength. Wag-
ner et al. (26) used the PCLM method of Ashcroft and
Heppleston (24) as well as TEM. Roggli (18) used scan-
ning electron microscopy (SEM) at a magnification of
1000 x to count all fibers with length greater than or
equal to 5 ,um. Both Warnock et al. (25) and Roggli (18)
counted asbestos bodies by conventional light micros-
copy. The median uncoated fiber count exceeds one mil-
lion (106) fibers pergram ofdried lungin allfive studies.
When these values are compared to the background
levels of pulmonary fiber burden in the general popu-
lation as reported by various laboratories (18,23,26,27),
it is observed that patients with asbestosis generally
have extremely high fiber burdens.
These observations fit well with epidemiologic data,
which indicate that asbestosis generally occurs in in-
dividuals with prolonged and heavy exposure to air-
borne asbestos fibers (28). In addition, the data suggest
that analysis of tissue asbestos burdens may be useful
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Table 2. Asbestos content of lung tissue in reported series of patients with asbestosis (18).a
Asbestos bodies/g Uncoated fibers/g
No. of cases Methodb dried lung dried lung Reference
8
23 PCLM (1.0-70) (23)
12.2 32
22 PCLM (0.49-192) (1.3-493) (24)
1.5
100 PCLM (0.001-31.6) (26)
0.378d 3.3d
76 SEMC (0.006-16) (0.18-125) (18)
0.123 5.68
22 TEMC (0.001-7.38) (1.6-121) (25)
372
170 TEM (< 1.0-10,000) (26)
aValues reported are the median counts for millions (106) of asbestos bodies or uncoated fibers per gram ofdried lung tissue, with ranges
indicated in parentheses, except for the study ofWagner et al. (26), where only the mean value could be obtained from the data presented.
bPCLM, phase contrast light microscopy; SEM, scanning electron microscopy; TEM, transmission electron microscopy.
'In these two studies, asbestos bodies were counted by conventional light microscopy.
dValues multiplied by a factor of 10 (approximate ratio of wet to dry lung weight) for purposes of comparison.
for distinguishing asbestosis from other types ofinter-
stitial fibrosis, including idiopathic varieties. Although
this distinction canbe made inthe vastmajorityofcases
by the identification ofasbestos bodies in histologic sec-
tion (2,18), cases have been reported in which asbestos
bodies could not be demonstrated histologically (29,30).
The problem is to determine what level offiber burden
shouldberequired todiagnoseasbestosisincaseswhere
asbestos bodies are not found in tissue sections. Most
ofthe data for uncoated fibers (Table 2) relate to fibers
which are 5 ,um or greater in length and suggest that
at least a million fibers per gram of dry lung tissue
should be present. This level is further supported by
the study of Roggli (18) correlating the histologic se-
verity of asbestosis with the tissue burden ofuncoated
fibers 5 ,um or greater in length. The regression line in
this study had an intercept of 100,000 fibers/g wet lung
(approximately 106 fibers/g dry lung) at a histologic
score of 0 (i.e., no fibrosis).
Whereas the pathogenicity ofasbestos fibers 5 jtm or
greater in length is well established, that of shorter
fibers remains unproven (31,32) and is an arearequiring
further investigation. The problem is compounded by
the fact that short chrysotile fibers are a ubiquitous
contaminant, they are difficult to count accurately (33),
and they may be found in substantial numbers within
lung tissues of individuals from the general population
(27). There is insufficient data in the literature to sug-
gest any level of short fibers as a criterion for the di-
agnosis of asbestosis. Short fibers are usually present
inlungtissueinsubstantiallygreaternumbersthanlong
fibers (i.e., : 5 ,im in length) (11,27). Therefore, it is
difficult to accurately assess the numbers oflong fibers
that are present in studies employing TEM to count all
visible fibers at a high magnification (e.g., 20,000 x or
greater). One suggestion for future correlative pathol-
ogy fiber burden studies employing TEM is the use of
a stratified counting scheme that takes into account the
numbers and dimensions ofboth short and long fibers.
Although there is a good correlation between num-
bers of fibers per gram of lung tissue and severity of
pulmonary interstitial fibrosis (18,23-26), there is a
wide scatter in the data, indicating that factors other
thantissue fiberburden are involved indeterminingthe
ultimate degree of fibrosis which develops (18,24). In
this regard, studies by Timbrell et al. (34,35) have
shown that in individuals exposed to the various types
ofamphibole asbestos, the severity ofpulmonary fibro-
sis correlates better with the relative fiber surface area
per unit weight of tissue than with the relative fiber
number or mass, as determined by magnetic alignment
and light scattering. These observations need tobe con-
firmed by electronmicroscopictechniquesthattakeinto
account not only fiber number, mass, and relative sur-
face area, abut also fiber dimensions and in particular
absolute numbers of long fibers. In addition, it is nec-
essary to determine which ifany ofthese factors apply
toasbestosis duetotheinhalationofchrysotile. Arecent
study in this regardby Churget al. (36) showed adirect
correlation between fiber concentration and severity of
fibrosis for both chrysotile and contaminating tremolite
fibers, but no correlation offibrosis with fiber size, sur-
face area, or mass for chrysotile and an inverse corre-
lation with fiber length, aspect ratio, and surface area
fortremolite. Clearly, furtherstudiesofthemineralogic
correlates of fiber-induced pulmonary fibrosis are
needed.
Mesothelloma
Mesothelioma is amalignant tumor that derives from
the serosalliningofthebodycavities. Themostcommon
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site of origin is the pleura, followed by the peritoneum
and pericardium. The pathologic features of these tu-
mors have beenreviewed elsewhere (2,37,38). Mesothe-
lioma is a rare form of malignancy, and its occurrence
is strongly associated with exposure to asbestos fibers
decades prior to the development of clinical symptoms
(1,28,39). Epidemiologic studies have shown that me-
sothelioma can develop years after brief or low level
exposures, and recent studies have indicated that there
are cases of mesothelioma for which no prior exposure
to asbestos canbeidentified (37,40,41). Therefore, there
has been considerable interest in the mineral fiber con-
tent of the lung in patients with mesothelioma.
Several studies have examined the asbestos content
of lung tissue in series of patients with mesothelioma
(23,42-47). These data are summarized inTable3. Com-
parison with the data in Table 2 shows that there is
considerable overlap of fiber content among patients
with asbestosis and mesothelioma. This is not surpris-
ing, since according to Antman (48), about 20% of pa-
tients with pleural mesothelioma also meet criteria for
asbestosis [26% in the series ofWhitwell et al. (23), 21%
in the series of Roggli et al. (46)]. Studies examining
the pulmonary fiber burdens in groups ofpatients with
asbestosis versus mesothelioma have shown that me-
sothelioma may occur with fiber burdens considerably
less than are required to produce asbestosis (23,46).
This observation is in agreement with the epidemiologic
findings noted above. One very important exception to
thisobservation hasbeenreported inminers and millers
of chrysotile asbestos (49). In these patients, the total
fiber burden in chrysotile workers with mesothelioma
is considerably greater than the median fiber concen-
trations in workers with asbestosis. Furthermore, the
ratio of tremolite (a contaminant of chrysotile ore) to
chrysotile is considerably greater in the lungs of the
workers with mesothelioma than in the workers with
asbestosis (44,49). These observations and scattered re-
ports ofmesothelioma occurring in individuals exposed
environmentally to tremolite have led some investiga-
tors to propose that it is the tremolite component ofthe
chrysotile ore which is responsible for the development
of mesothelioma in chrysotile mine workers (49).
In consideration ofStanton's observations that fibers
greater than 8.0 ,um in length and less than 0.25 ,m in
diameter are the most efficient at producing mesothe-
lioma experimentally (50), it is of interest to examine
fiber dimension data in studies of human lungs with
regard tomesothelioma. The studybyChurgand Wiggs
(43) of amphibole-induced mesothelioma showed that
39% ofamosite fibers and 23% ofcrocidolite fibers were
5 ,um or greater in length. In contrast, the study by
Churg et al. (44) of chrysotile-related mesotheliomas
showed that only 11% of chrysotile fibers and 13% of
tremolite fibers exceeded 5 ,um in length. The vast ma-
jority of fibers in both studies were less than 0.25 ,um
in diameter (43,44). Lippmann (35) concluded in his re-
view of the human and animal data that it is primarily
fibers greater than 5 ,um in length and less than 0.1 p,m
in diameter that are responsible for the development of
mesotheliomas. The fiber dimension and fiber burden
data from chrysotile versus amphibole-induced meso-
thelioma in humans are consistent with either the hy-
pothesis that a) large numbers ofshort (<5 ,m) asbes-
tos fibers are carcinogenic forthe pleura in man, orthat
b) large burdens are necessary to provide sufficient
Table 3. Asbestos content of lung tissue in reported series of patients with mesothelioma.a
Asbestos bodies/g Uncoated fibers/g
No. of cases Methodb dried lung dried lung Reference
0.75
100 PCLM (0-70) (23)
11
15 SEM (2-490) (42)
2.4
14 SEM (0.4-37) (45)
48d 0.81d
19 SEMC (0.002-9770) (0.012-28.9) (46)
3.5
10 TEM (0.1-85.2) (43)
238
6 TEM (52-2190) (44)
3.2
20 TEMe (0.04-450) 18 (47)
aValues reported are the median counts for thousands (103) of asbestos bodies or millions (106) of uncoated fibers per gram ofdried lung
tissue, with ranges indicated in parentheses, except for the study of Gaudichet et. al. (47), where only the mean value for total fibers per gm
dried lung could be obtained from the data presented.
bPCLM, phase contrast light microscopy; SEM, scanning electron microscopy; TEM, transmission electron microscopy.
cIn these two studies, asbestos bodies were counted by conventional light microscopy.
dValues multiplied by a factor of 10 (approximate ratio of wet to dry lung weight) for purposes ofcomparison.
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numbers of"Stanton-sized" tremolite fibers. However,
the data are also consistent with a third possibility: due
tochrysotile's fragility andtendencytobreakintosmall
individual fibrils, very high exposure levels are neces-
sary to maintain a sufficient level of "Stanton-sized"
chrysotile fibers in contact with the pleura. This latter
hypothesis may be applicable to possible mesothelioma
risksfromnonasbestosmineralfibers, suchasmanmade
mineral fibers, many ofwhich are either soluble invivo
(51) or tend to fracture transversely, resulting in
shorter fibers that may be more readily cleared from
the lung (52).
An area requiring further study is the migration and
distribution ofamphibole versus chrysotile fibers to the
visceral and parietal pleura. It is reasonable to assume
that fibers actually reaching the pleura are the ones
responsible for diseases of the pleura, and the dimen-
sions and types offibers accumulating in the pleura are
notnecessarilysimilartothoseaccumulatinginthelung
parenchyma. In this regard, Sebastien et al. (53) re-
ported that in individuals exposed to mixtures offibers,
there was a relative accumulation of longer amphibole
fibers inthelungparenchyma, whereas shortchrysotile
fibers accumulate in the pleura. However, Churg et al.
(44) were unable to find a difference in the size or type
of fibers isolated from peripheral versus central lung
parenchyma in Canadian chrysotile workers. One prob-
lem with such studies isthat samples ofperipheral lung
necessarily include a large proportion of lung paren-
chyma, so that any differences between fiber content of
lung parenchyma and visceral pleura per se would be
masked or minimized. Although there are substantial
data now available on the fiber content of lung paren-
chyma from the general population with various ana-
lyticaltechniques (23,27,46,47), no comparable data ex-
ist for the visceral and parietal pleura. Furthermore,
the migration offibers from the lungs to the peritoneal
cavity needs to be further clarified.
Benign Pleural Disease
The most common pathologic abnormality related to
the inhalation of asbestos fibers is the parietal pleural
plaque. These lesions occur as circumscribed, elevated
areas ofpleural thickening with a cartilaginous consis-
tency, located most often over the domes of the dia-
phragm oralongthe posterolateral chest wall overlying
the ribs (2). They are ivory colored with a smooth or
knobby surface (the latter resembling candle wax drip-
pings), andmaybecalcified. Otherpleuralabnormalities
related to asbestos exposure include diffuse visceral
pleural fibrosis, rounded atelectasis, and benign asbes-
tospleural effusion. These abnormalities apparently re-
sult from inflammation and repair stimulated by asbes-
tos fibers reaching the pleural surface. Epidemiologic
studies indicate that benign asbestos-related pleural
diseases may develop following brief or low level ex-
posures (1,28).
Several studies have examined the asbestos content
oflungtissue in series ofpatients withbenign asbestos-
related pleural disease (42,54-57). Most ofthese have
dealt with parietal pleural plaques, and the studies are
summarized in Table 4. These data show that patients
with parietal pleural plaques have tissue fiber burdens
that are on the average substantially lower than those
ofpatients with asbestosis (Table 2 vs Table 4) and are
somewhat lower than but of about the same order of
magnitude as patients with mesothelioma (Table 3 vs
Table 4). The studies by Warnock et al. (54) and Churg
(55) both showed a significant increase in the concen-
trations of commercial amphiboles (amosite or croci-
dolite)inthelungs ofpatientswithplaquesascompared
to a reference population, but no significant differences
for chrysotile or noncommercial amphiboles. Whitwell
et al. (23) included 21 patients with pleural plaques in
their normal control series of 100 cases, and found that
55% of the cases with more than 20,000 fibers/g by
PCLM but only 5.5% of cases with fewer than 20,000
fibers/g had plaques. All ofthese observations support
a role for asbestos fibers in the production of pleural
plaques and confirm the epidemiologic findings that
plaques may develop following brief or low-level ex-
posures. The study of patients with diffuse pleural fi-
brosis by Stephens et al. (57) indicates that these pa-
tients have on the average a greater fiber burden than
patients with plaques alone, but less than patients with
asbestosis (Table 2 vs Table 4).
Many ofthe questions raised in the previous section
with respect to mesothelioma also apply to benign as-
bestos-related pleural disease, particularly in regard to
migration of fibers to the pleura. The mechanism of
formation of pleural plaques and their peculiar locali-
zation to the parietal pleura is poorly understood, es-
pecially in terms ofthe dimensions and types offibers
that gain access to this compartment.
Carcinoma of the Lung
The association between asbestos exposure and an
increased risk forlungcancerhas beenwell-established
epidemiologically (1,28,32), and cigarette smoking and
asbestos appear to act in a synergistic fashion to in-
crease this risk (58). The pathologic features of lung
cancer among asbestos workers are similar to those of
nonexposed cigarette smokers, showing the same dis-
tribution of histologic patterns (46,59). There is an in-
creased predominance oflower lobe cancers among as-
bestos workers in contrast to the upper lobe pre-
dominance in nonexposed cigarette smokers (60). The
association between asbestos-exposure and lung cancer
is widely accepted for patients with asbestosis, and
some investigators have proposed the concept that
these tumors are scar cancers. However, only a minor-
ity of cases fit the classic concept of a peripheral scar
carcinoma, and most are the usual bronchogenic carci-
noma. Whether lung cancers occurring in cigarette
smoking asbestos workers without asbestosis can be
partly attributed to the asbestos exposure is a highly
controversial issue (61-66). It is therefore of interest
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Table 4. Asbestos content of lung tissue in reported series of patients with benign asbestos-related pleural disease.a
Asbestos bodies/g Uncoated fibers/g
No. of cases Methodb dried lung dried lung Reference
2.2
14 SEM (0.1-13) (42)
48.7c 0.5c
17 SEM (0-408) (0.007-1.74) (56)
7.8c 0.54c
20 TEMd (0.3-9,600) (0.018-71) (54)
17.3c 1.14c
29 TEMd (0-194) (ND) (55)
0.131
7e PCLM (0.029-0.378) (57)
28.9
TEM (9.2-83.5)
aValues reported are the median counts for thousands (103) of asbestos bodies or millions (106) of uncoated fibers per gram of dried lung
tissue, with ranges indicated in parentheses, except for the study ofChurg (55), where only the mean value for total fibers per gram was given
and a range could not be determined (ND).
bPCLM, phase contrast light microscopy; SEM, scanning electron microscopy; TEM, transmission electron microscopy.
'Values multiplied by a factor of 10 (approximate ratio of wet to dry lung weight) for purposes of comparison.
dIn these two studies, asbestos bodies were counted by conventional light microscopy.
'Cases in series of Stephens et al. (57) are diffuse pleural fibrosis. All others are parietal pleural plaques.
to review what has been learned from fiber burden lung and found similar asbestos body and fiber counts
analysis in this regard. in these two groups as compared to 20 patients with
Several studies have examined the asbestos content pulmonary metastases and 20 with cardiovascular dis-
of lung tissue in series of patients with lung cancer ease. Roggli(56) studied 30selectedcasesoflung cancer
(23,25,47,56,67) andthese dataare summarizedin Table with some history of asbestos exposure, but without
5. The valuesreported depend notonly onthe analytical asbestosis or pleural plaques. The series ofWarnock et
techniques employed by the various authors, but on the al. (25)included 7of9caseswithhistologicallyconfirmed
way the cases were selected as well. Whitwell et al. asbestosis, and the series ofWarnock and Isenberg (67)
(23) examined 100 consecutive cases oflung cancer and included 12 of 62 cases with asbestosis. These studies
found very similar results between cancer cases and indicate that in populations with no appreciable occu-
controls. Gaudichet et al. (47) included 20 patients with pational exposure to asbestos and with substantial ex-
squamous carcinoma and 20 with adenocarcinoma ofthe posure to cigarette smoke, there is little evidence for a
Table 5. Asbestos content of lung tissue in reported series of patients with lung cancer.a
Asbestos bodies/g Uncoated fibers/g
No. of cases Methodb dried lung dried lung Reference
0.009
100 PCLM (0-0.115) (23)
11.8c 0.25c
30 SEM (0-510) (0.007-1.74) (56)
0.16
40 TEMd (0-290) 16 (47)
35.6 5.83
9 TEMd (0.41-840) (3.10-73.3) (25)
3.75 2.18
75 TEMd (0-1000) (0.077-97) (67)
aValues reported are the median counts for thousands (103) of asbestos bodies or millions (106) of uncoated fibers per gram of dried lung
tissue, with ranges indicated in parentheses, except for the study ofGaudichet et al. (47), where only the mean value for total fibers per gram
dried lung could be obtained from the data presented.
bPCLM, phase contrast light microscopy; SEM, scanning electron microscopy; TEM, transmission electron microscopy.
'Values multiplied by a factor of 10 (approximate ratio of wet to dry lung weight) for purposes of comparison.
dIn these three studies, asbestos bodies were counted by conventional light microscopy.
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Table 6. Asbestos content of lung tissue in reference or control populations.a
Asbestos bodies/g Uncoated fibers/g
No. of cases Methodb dried lung dried lung Reference
0.007
100 PCLM (0-0.521) (23)
0.020d 0.034d
10 SEMc (0-0.22) (0.016-0.056) (22)
0.25
28 SEM (0-4.8) (45)
0.28d 1.29d
20 TEMC (0.02-0.84) (0.260-7.55) (27)
0.18
20 TEMc (0-3.2) 11.2 (47)
23 TEM 0.62 (72)
aValues reported are the median counts for thousands (103) of asbestos bodies or millions (106) of uncoated fibers per gram of dried lung
tissue, with ranges indicated in parentheses, except for the study ofGaudichet et al. (47), where only the mean value for total fibers per gram
dried lung could be obtained from the data presented.
bPCLM, phase contrast light microscopy; SEM, scanning electron microscopy; TEM, transmission electron microscopy.
'In these three studies, asbestos bodies were counted by conventional light microscopy.
dValues multiplied by a factor of 10 (approximate ratio of wet to dry lung weight) for purposes of comparison.
contributing role for asbestos in these cancers (23,47)
andthatinpopulationswithsomeoccupationalexposure
to asbestos but without asbestosis, the tissue asbestos
burden is greater than that ofthe general, nonexposed
population (25,56,67). These studies do not prove
whether asbestos is a substantial contributing factor to
the lung cancers in those patients exposed to asbestos
who do not have asbestosis.
These observations are not surprising when one con-
siders that 85 to 90% oflung cancers occurring annually
in the United States are attributable to cigarette smok-
ing, whereas as few as 2% of cases may be related to
asbestos exposure (68). However, the association of
lung cancer with asbestosis is truly astounding, with
somewhere between 40 and 65% ofindividuals with as-
bestosis ultimately succumbing to carcinoma ofthe lung
(1,28,69). Indeed, it is quite possible that the excess
numbers oflung cancers occurring in asbestos-exposed
populations are entirely attributable to those occurring
inindividuals with asbestosis (61), although others have
arguedthatitis the amount ofasbestos exposure rather
than the fibrotic reaction that is the determining factor
(67). In order to resolve this issue, it will be necessary
to study tissue fiber burdens in cohorts of asbestos
workers who do not have asbestosis. One could then
use logistic analysis to compare fiber burden levels and
smoking history in individuals dying from lung cancer
versus other causes of death. In this manner, it could
be determined whether differences are explainable by
smoking habit alone or if fiber burden is a separate
contributing factor. Fiber dimensions are probably im-
portant as well, and in this regard, Lippmann (35) con-
cluded in his review ofthe human and animal data that
it is primarily fibers greater than 10 ,um in length and
greater than 0.15 ,um in diameter that are responsible
for development of lung cancer.
Furtherstudy ofthe possible role ofnonasbestos min-
eral fibers and nonfibrous mineral particles in the path-
ogenesis oflung cancer is also needed. It has been sug-
gested that the increased numbers ofmineralfibers and
particles found in the lungs ofsmokers with lungVancer
as compared toagroup ofage-matched smokerswithout
lung cancer may play a pathogenetic role (70). Alter-
natively, smokers who develop lung cancer may simply
have genetically determined less efficient clearance
mechanisms for fibers, particles, tars, and associated
carcinogens that mayfind theirway intothe respiratory
tract (71).
Normal Lungs
Determination of background levels of fibers to be
expected in the general population is an extraordinarily
difficult task because it is no simple matter to define
what is normal or to exclude unknown exposures. Sev-
eral investigators have established ranges offiber bur-
dens identified in control or reference populations
(22,23,27,45,47,72), and some of these are summarized
in Table 6. The variations inreported values can largely
be accounted for by methodologic differences and pa-
tient selection criteria. In any analysis of fiber burden
data in a population with a given disease, it is ofcritical
importance to compare the findings with those of an
appropriate reference or control population for which
the same analytical technique was employed.
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